0.92
price down icon2.25%   -0.0212
after-market 시간 외 거래: .90 -0.02 -2.17%
loading
전일 마감가:
$0.9412
열려 있는:
$0.9411
하루 거래량:
201.95K
Relative Volume:
0.80
시가총액:
$38.68M
수익:
-
순이익/손실:
$-81.22M
주가수익비율:
-0.2997
EPS:
-3.07
순현금흐름:
$-74.41M
1주 성능:
-3.90%
1개월 성능:
+13.69%
6개월 성능:
-23.33%
1년 성능:
-16.36%
1일 변동 폭
Value
$0.851
$0.9411
1주일 범위
Value
$0.81
$1.10
52주 변동 폭
Value
$0.49
$1.93

Xilio Therapeutics Inc Stock (XLO) Company Profile

Name
명칭
Xilio Therapeutics Inc
Name
전화
617-833-1027
Name
주소
828 WINTER STREET, WALTHAM
Name
직원
73
Name
트위터
Name
다음 수익 날짜
2024-11-09
Name
최신 SEC 제출 서류
Name
XLO's Discussions on Twitter

XLO을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
XLO 0.92 38.68M 0 -81.22M -74.41M -3.07
VRTX 450.37 115.10B 10.63B -479.80M -1.35B 13.33
REGN 744.50 82.04B 13.85B 4.65B 3.32B 35.06
ARGX 596.74 35.07B 1.86B -40.29M -1.28B -4.16
ALNY 246.80 32.20B 2.09B -332.26M 16.06M -4.14
BNTX 108.23 25.09B 3.30B -501.07M 1.03B 11.54

Xilio Therapeutics Inc Stock (XLO) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2022-12-21 개시 Chardan Capital Markets Buy
2022-01-10 개시 H.C. Wainwright Buy
2021-11-16 개시 Cowen Outperform
2021-11-16 개시 Guggenheim Buy
2021-11-16 개시 Morgan Stanley Overweight
2021-11-16 개시 Raymond James Outperform
모두보기

Xilio Therapeutics Inc 주식(XLO)의 최신 뉴스

pulisher
Nov 11, 2024

Raymond James Cuts Xilio Therapeutics (NASDAQ:XLO) Price Target to $4.00 - Defense World

Nov 11, 2024
pulisher
Nov 08, 2024

Xilio Therapeutics Reports Q3 2024 Progress and Financials - TipRanks

Nov 08, 2024
pulisher
Nov 07, 2024

Xilio Therapeutics Inc. (XLO) Quarterly 10-Q Report - Quartzy

Nov 07, 2024
pulisher
Nov 07, 2024

Xilio to present new cancer treatment data at SITC - Investing.com

Nov 07, 2024
pulisher
Nov 07, 2024

Xilio Therapeutics Announces Pipeline and Business Updates and Third Quarter 2024 Financial Results - citybiz

Nov 07, 2024
pulisher
Nov 07, 2024

Xilio Therapeutics Announces Initial Clinical Trial Data - GlobeNewswire

Nov 07, 2024
pulisher
Nov 07, 2024

Xilio's Cancer Drug Shows Promise: Liver Metastasis Resolution in Clinical Trial | XLO Stock News - StockTitan

Nov 07, 2024
pulisher
Nov 07, 2024

Xilio to present new cancer treatment data at SITC By Investing.com - Investing.com Canada

Nov 07, 2024
pulisher
Oct 30, 2024

Xilio Therapeutics to Present Initial Phase 1C Dose - GlobeNewswire

Oct 30, 2024
pulisher
Oct 30, 2024

Xilio Therapeutics to Present Initial Phase 1C Dose Escalation Data for XTX101 (Vilastobart) in Combination with Atezolizumab in a Late-Breaker Poster at the Society for Immunotherapy of Cancer (SITC) 39th Annual Meeting - GlobeNewswire Inc.

Oct 30, 2024
pulisher
Oct 25, 2024

Companies Like Xilio Therapeutics (NASDAQ:XLO) Are In A Position To Invest In Growth - Simply Wall St

Oct 25, 2024
pulisher
Oct 04, 2024

Xilio Therapeutics Announces Upcoming Poster Presentation - GlobeNewswire

Oct 04, 2024
pulisher
Oct 04, 2024

Xilio Therapeutics Announces Upcoming Poster Presentation at the Society for Immunotherapy of - The Bakersfield Californian

Oct 04, 2024
pulisher
Oct 04, 2024

Xilio Therapeutics Announces Upcoming Poster Presentation at the Society for Immunotherapy of Cancer (SITC) 39th Annual Meeting - StockTitan

Oct 04, 2024
pulisher
Oct 02, 2024

Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - ForexTV.com

Oct 02, 2024
pulisher
Sep 23, 2024

XOS stock touches 52-week low at $4.62 amid market challenges - Investing.com

Sep 23, 2024
pulisher
Sep 23, 2024

XBP stock plunges to 52-week low at $1.05 amid market challenges - Investing.com

Sep 23, 2024
pulisher
Sep 23, 2024

XPEV: Riding the Market Waves of Growth and Decline in 2023 - The InvestChronicle

Sep 23, 2024
pulisher
Sep 23, 2024

Xilio Therapeutics Inc (XLO) rating initates by Chardan Capital Markets - Knox Daily

Sep 23, 2024
pulisher
Sep 23, 2024

Market Resilience: XTI Aerospace Inc. (XTIA) Finishes Weak at 0.22, Down -4.06 - The Dwinnex

Sep 23, 2024
pulisher
Sep 23, 2024

Tencent-Backed AI Drug Researcher Xtalpi’s Shares Double On Revenue Rise - Forbes Africa

Sep 23, 2024
pulisher
Sep 23, 2024

Xilio Therapeutics Inc (XLO)’s highs and lows: A closer look at its stock price fluctuations - US Post News

Sep 23, 2024
pulisher
Sep 23, 2024

(XFLT) Trading Signals - Stock Traders Daily

Sep 23, 2024
pulisher
Sep 23, 2024

Balance Sheet Breakdown: Xilio Therapeutics Inc (XLO)’s Debt-to-Equity and Long-Term Debt/Eq Ratios - The Dwinnex

Sep 23, 2024
pulisher
Sep 23, 2024

There’s evidence fragile X symptoms can be reduced with an experimental drug - KUOW News and Information

Sep 23, 2024
pulisher
Sep 22, 2024

Slew of New Drugs Sends Xencor Shares Soaring - Los Angeles Business Journal

Sep 22, 2024
pulisher
Sep 21, 2024

XBiotech (NASDAQ:XBIT) Shares Pass Above 50 Day Moving Average of $6.63 - Defense World

Sep 21, 2024
pulisher
Sep 20, 2024

XTX Topco Ltd Has $2.01 Million Stock Position in IQVIA Holdings Inc. (NYSE:IQV) - Defense World

Sep 20, 2024
pulisher
Sep 14, 2024

Xilio Therapeutics faces Nasdaq delisting over share price - Investing.com India

Sep 14, 2024
pulisher
Sep 14, 2024

Xilio Therapeutics faces Nasdaq delisting over share price By Investing.com - Investing.com Australia

Sep 14, 2024
pulisher
Sep 05, 2024

XLO Stock Sees Decline of Approximately -10.26% in Last Five Days - Knox Daily

Sep 05, 2024
pulisher
Sep 02, 2024

Analytical Lens: Exploring Xilio Therapeutics Inc (XLO)’s Financial Story Through Ratios - The Dwinnex

Sep 02, 2024
pulisher
Aug 28, 2024

Xilio Therapeutics to Present at Morgan Stanley 22nd Annual Global Healthcare Conference - GlobeNewswire

Aug 28, 2024
pulisher
Aug 20, 2024

Xilio Therapeutics shares hold Buy rating on clinical trial focus - Investing.com

Aug 20, 2024
pulisher
Aug 20, 2024

Xilio Therapeutics shares hold Buy rating on clinical trial focus By Investing.com - Investing.com Canada

Aug 20, 2024
pulisher
Aug 08, 2024

Xilio Therapeutics Announces Pipeline and Business Updates and Second Quarter 2024 Financial Results - GlobeNewswire

Aug 08, 2024
pulisher
Jul 31, 2024

Understanding the Risks of Investing in Xilio Therapeutics Inc (XLO) - Knox Daily

Jul 31, 2024
pulisher
Jul 28, 2024

Xilio Therapeutics, Inc. (NASDAQ:XLO) Short Interest Update - Defense World

Jul 28, 2024
pulisher
Jul 12, 2024

Here's Why We're A Bit Worried About Xilio Therapeutics' (NASDAQ:XLO) Cash Burn Situation - Simply Wall St

Jul 12, 2024
pulisher
Jul 06, 2024

Head to Head Analysis: Indivior (NASDAQ:INDV) versus Xilio Therapeutics (NASDAQ:XLO) - Defense World

Jul 06, 2024
pulisher
Jun 29, 2024

Can Xilio Therapeutics (NASDAQ:XLO) Afford To Invest In Growth? - Yahoo Finance

Jun 29, 2024
pulisher
Jun 28, 2024

Short Interest in Xilio Therapeutics, Inc. (NASDAQ:XLO) Drops By 83.1% - Defense World

Jun 28, 2024
pulisher
Jun 25, 2024

$82 million series A round propels Exsilio into gene editing race - The Pharma Letter

Jun 25, 2024
pulisher
Jun 22, 2024

Head to Head Analysis: Xilio Therapeutics (NASDAQ:XLO) versus VBI Vaccines (NASDAQ:VBIV) - Defense World

Jun 22, 2024
pulisher
Jun 21, 2024

Biopharma Layoff Tracker 2024: Ginkgo, Cara, Barinthus and More Cut Staff - BioSpace

Jun 21, 2024
pulisher
Jun 19, 2024

Xilio Therapeutics Inc (XLO) stock analysis: A comprehensive overview – US Post News - US Post News

Jun 19, 2024
pulisher
Jun 19, 2024

Investing in Xilio Therapeutics Inc (XLO): What You Must Know – Knox Daily - Knox Daily

Jun 19, 2024
pulisher
Jun 19, 2024

Xilio Therapeutics Inc (XLO)'s Market Momentum: Closing Strong at 0.95, Down -0.33 – DWinneX - The Dwinnex

Jun 19, 2024
pulisher
Jun 15, 2024

Xilio Therapeutics, Inc. (NASDAQ:XLO) Shares Sold by Octagon Capital Advisors LP - Defense World

Jun 15, 2024
pulisher
Jun 14, 2024

Xilio Therapeutics expands board with industry experts - Investing.com India

Jun 14, 2024
pulisher
Jun 14, 2024

Xilio Therapeutics expands board with industry experts By Investing.com - Investing.com

Jun 14, 2024

Xilio Therapeutics Inc (XLO) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$70.39
price down icon 0.93%
$18.42
price down icon 1.07%
$38.25
price up icon 3.55%
$367.36
price up icon 0.83%
$194.56
price up icon 0.15%
$108.23
price up icon 5.96%
자본화:     |  볼륨(24시간):